Intravenous streptokinase given within 0-4 hours of onset of myocardial infarction reduced mortality in ISIS-2.
D002986:Clinical Trials as Topic; D006801:Humans; D007262:Infusions, Intravenous; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D011897:Random Allocation; D013300:Streptokinase / Q000008:administration & dosage*; D013997:Time Factors
D013300:Streptokinase